<p>A series of semicarbazone, thiosemicarbazone, and aminoguanidine derivatives were synthesized and tested as antitrypanosomal agents. The theoretical NMR of the compounds was calculated using molecular modeling techniques (density functional theory (DFT) calculations) and confirmed the formation of the compounds. The ability to inhibit cruzain and <i>Trypanosoma cruzi</i> epimastigote replication was evaluated. Cruzain inhibition ranged between 70 and 75% (100 μM), and IC<sub>50</sub> values observed in epimastigote forms of <i>T. cruzi</i> ranged from 20 to 140 μM. Furthermore, the compounds did not present cytotoxicity at concentrations up to 50 and 250 μM in MTT tests. Molecular modeling studies were conducted using DFT method (B3LYP f...
Chapter 1. The development of inhibitors of cruzain, the major cysteine protease of the Trypanosoma...
The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention ...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvime...
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thia...
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thia...
Human parasitic diseases are the foremost threat to human health and welfare around the world. Trypa...
Human parasitic diseases are the foremost threat to human health and welfare around the world. Trypa...
The development of cruzain inhibitors has been driven by the urgent need to develop novel and more e...
American Trypanosomiasis or Chagas’ disease is a tropical disease caused by Trypanosoma cruzi, a pa...
Chagas` disease is a parasitic infection widely distributed throughout Latin America, with devastati...
Chagas disease is caused by Trypanosoma cruzi (T. cruzi) protozoan and is considered by WHO as a neg...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...
Chagas` disease is a parasitic infection widely distributed throughout Latin America, with devastati...
Chapter 1. The development of inhibitors of cruzain, the major cysteine protease of the Trypanosoma...
The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention ...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvime...
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thia...
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thia...
Human parasitic diseases are the foremost threat to human health and welfare around the world. Trypa...
Human parasitic diseases are the foremost threat to human health and welfare around the world. Trypa...
The development of cruzain inhibitors has been driven by the urgent need to develop novel and more e...
American Trypanosomiasis or Chagas’ disease is a tropical disease caused by Trypanosoma cruzi, a pa...
Chagas` disease is a parasitic infection widely distributed throughout Latin America, with devastati...
Chagas disease is caused by Trypanosoma cruzi (T. cruzi) protozoan and is considered by WHO as a neg...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...
Chagas` disease is a parasitic infection widely distributed throughout Latin America, with devastati...
Chapter 1. The development of inhibitors of cruzain, the major cysteine protease of the Trypanosoma...
The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention ...
Inhibition of the Trypanosoma cruzi cysteine protease cruzain has been proposed as a therapeutic app...